The automated analyzers market covers equipment and devices
that are used to perform clinical tests in laboratories without any human
intervention. Automated analyzers greatly reduce manual intervention and errors
by automating the sample handling and processing.They are used to analyze
biological samples like blood, urine, and tissue in clinical laboratories for
diagnostic testing. The adoption of automated analyzers helps in improving
workflow efficiency, reduce turnaround times, increase productivity and handle
a high volume of samples. The increasing complexity of medical testing and
focus on delivering faster diagnostics is driving the need for automated, high-throughput
equipment in clinical laboratories. This has significantly boosted the demand
for advanced automated analyzers globally.
The Global automated analyzers market is estimated to be valued at US$ 5.56 Bn in 2024 and is expected to
exhibit a CAGR of 9.9% over the
forecast period 2024 to 2031.
Key Takeaways
Key players operating in the automated analyzers market are Abbott, Danaher,
Thermo Fisher Scientific, Inc., Becton Dickinson, Agilent Technologies, Inc.,
Zimed Healthcare Inc., Biobase Biodusty(Shandong), Co., Ltd., Chongqing Drawell
Instrument CO,.Ltd, Transasia Bio-Medicals, Awareness Technology, Inc.,
Trivitron Healthcare, Getein Biotech, Inc., Eppendorf AG, Honeywell
International, Inc., Aurora Biomed, HORIBA, Ltd., Beckman Coulter, Inc. These
players are focusing on new product launches and expanding their presence
globally to strengthen their
Automated
Analyzers Market Size position.
The growing demand for clinical diagnostic testing, increasing prevalence of
chronic and infectious diseases, and rising geriatric population are expected
to offer significant growth opportunities for players in the automated
analyzers market. Major players are focusing their efforts on emerging markets
in Asia Pacific and Latin America which are expected to witness high demand owing
to improving healthcare infrastructure and increasing medical spending in these
regions.
Abbott and Thermo Fisher Scientific have expanded their global footprint
through acquisitions to gain access to new technologies and additional markets.
Other players are also focusing on strategic collaborations and agreements with
regional diagnostic players and laboratories to increase penetration in
international markets.
Market Drivers
Growing prevalence of chronic and infectious diseases is
significantly boosting the demand for clinical diagnostic testing globally.
According to the World Health Organization, chronic diseases are estimated to
account for nearly 60% of all deaths worldwide. This high disease burden has
increased the need for faster test result delivery using automated
high-throughput analyzers.
Market Restrains
High costs associated with automated analyzers and their
maintenance is a major challenge, especially for small- and medium-sized
clinical laboratories in developing regions. The lack of skilled technicians to
operate sophisticated automated systems in these settings also hampers market
growth. Additionally, stringent regulatory approval processes and quality
standards for these systems increase compliance burden on market players.
Segment
Analysis
The automated analyzers market can be segmented into
clinical and point-of-care analyzers. Clinical analyzers dominated more than
50% of the market share in 2024 due to their widespread adoption in hospitals
and diagnostics labs for high volume sample testing. Clinical analyzers offer
faster turnaround time, accuracy, and reliability for analyzing liquid samples
like blood and urine. Point-of-care analyzers are gaining popularity due to
growing need for near patient testing and quick diagnostic results. This
segment is expected to witness higher growth during the forecast period.
Global Analysis
Regionally, North America held the largest share of the
automated analyzers market in 2024 owing to presence of major players,
increasing geriatric population and rising cases of chronic diseases. The
growth in this region can be attributed to growing demand from clinical
laboratories and hospitals for timely diagnostic test results. Europe captured
the second largest market share due to favorable reimbursements for clinical
tests and rising healthcare spending. Asia Pacific is expected to witness
fastest growth during the forecast period supported by improving healthcare
infrastructure, growing medical tourism, and increasing awareness regarding
disease diagnosis in countries like India, China and Japan. Rising government
initiatives for modernizing healthcare facilities are fueling adoption of
automated platforms in developing nations of Latin America and Middle-East
& Africa.
Get More
Insights On-
Automated
Analyzers Market Size
Comments
Post a Comment